Mutant IDH in Gliomas: Role in Cancer and Treatment Options.
Solomou G. et al, (2023), Cancers (Basel), 15
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors.
Reinbold R. et al, (2022), Nat Commun, 13
Anion-exchange chromatography mass spectrometry provides extensive coverage of primary metabolic pathways revealing altered metabolism in IDH1 mutant cells.
Walsby-Tickle J. et al, (2020), Commun Biol, 3
Serum- and Glucocorticoid-induced Kinase Sgk1 Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis.
Lee LYW. et al, (2019), Clin Cancer Res, 25, 629 - 640
The role of inflammation in subventricular zone cancer.
Bardella C. et al, (2018), Prog Neurobiol, 170, 37 - 52
Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis.
Hollinshead KER. et al, (2018), Cell Rep, 22, 3107 - 3114
Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
Irshad S. et al, (2017), J Pathol, 242, 178 - 192
Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis.
Bardella C. et al, (2016), Cancer Cell, 30, 578 - 594
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.
Kovac M. et al, (2015), Nat Commun, 6
Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.
Davis H. et al, (2015), Nat Med, 21, 62 - 70
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
Krell D. et al, (2013), Future Oncol, 9, 1923 - 1935
BONE MORPHOGENETIC PROTEIN (BMP) PATHWAY DYSREGULATION SUBVERTS ONCOGENE INDUCED SENESCENCE MECHANISMS IN THE SERRATED PATHWAY OF TUMOURIGENESIS
Boitsova T. et al, (2013), GUT, 62, A200 - A200
Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.
Bardella C. et al, (2012), Mol Cell Biol, 32, 3081 - 3094
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
Schödel J. et al, (2012), Nature Genetics, 44, 420 - 425
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.
Schödel J. et al, (2012), Nat Genet, 44, 420 - S2
SDH mutations in cancer
Bardella C. et al, (2011), Biochimica et Biophysica Acta - Bioenergetics, 1807, 1432 - 1443
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.
Bardella C. et al, (2011), J Pathol, 225, 4 - 11